Podcasts about Specialty pharmacy

In this powerful episode of This Week in Pharmacy, Todd Eury explores the growing national backlash against pharmacy benefit managers (PBMs)—starting with bold action in Arkansas. Following Gov. Sarah Huckabee Sanders' recent signing of legislation to limit PBM influence, Arkansas has become a flashpoint in the nationwide struggle to protect independent pharmacies and ensure fair drug pricing. Special guest from Arkansas, Doctor's Orders Pharmacy Owner, Lelan Stice, as we dig into what this legislation means, how states like Alabama are following suit, and why pharmacists across the U.S. are calling for transparency, accountability, and reform. PBMs are under increased legal and political scrutiny across multiple states Independent pharmacies are gaining new allies in their fight for survival Legislative momentum is growing—this could be a tipping point Patients, too, are paying the price for PBM overreach Pharmacists must stay informed and involved in local/state policy Full AP article: APNews.com – Arkansas Takes on PBMs TWIRx Feature: Lumicera Health Services Guest: Dr. Ben Heiser, PharmD – General Manager, Specialty Pharmacy, Lumicera Health Services In this special TWIRx segment, This Week in Pharmacy dives into the world of specialty pharmacy with Dr. Ben Heiser of Lumicera Health Services, a nationally recognized leader in delivering specialty drug solutions with a patient-first approach. Dr. Heiser discusses how Lumicera leverages data-driven care models, collaborative payer partnerships, and a commitment to access and affordability to redefine what it means to support patients with complex, chronic conditions. From pharmacy innovation to value-based outcomes, this interview offers a behind-the-scenes look at one of the most forward-thinking organizations in specialty care. Lumicera Health is the Pharmacy Podcast Network sponsor for the AXS25 Press Coverage, learn more about  Lumicera here:  https://www.lumicera.com/  Subscribe to all 40+ Pharmacy Podcast Network podcasts from one link:  https://linktr.ee/pharmacypodcast 

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jessie Heaton, PharmD, MBA, CSP, Vice President of Specialty and Infusion at Maxor, and Michelle Mulgrew, PharmD, Vice President of Commercial Specialty Market Development at Maxor, about specialty pharmacy's role in rare disease patient care management and how to empower patients, prescribers, and manufacturers to navigate complex clinical needs.  

In this episode, join moderator Brea Burmeister and experts Dr. Scott Weiner and Dr. Arjun Venkatesh as they explore how quality measures can transform opioid use disorder (OUD) care in emergency departments. Discover innovative metrics, quality improvement initiatives, and EHR data integration to optimize patient outcomes. Learn about overcoming barriers like stigma and resource shortages and get key recommendations from recent OUD treatment studies. Perfect for healthcare professionals and anyone interested in advancing OUD care.What You'll Learn:Challenges and opportunities of addressing the opioid epidemic in emergency medicineACEP's work on metrics and the development of quality improvement measuresKey quality initiatives to enhance OUD care and reduce harmThe barriers to adopting these initiatives and strategies to overcome themRecommendations based on recent studies in OUD treatment and medicationMODERATOR: Brea BurmeisterMember, CHIME Opioid Task ForceBio: With 23 years in healthcare, Brea specializes in managing relationships within Integrated Delivery Network (IDN) Health Systems, regional Group Practices, and Specialty Pharmacy accounts. She strengthens value-based care models by developing strategic plans, analyzing performance data, improving care coordination, and implementing process improvements. Brea's work enhances patient outcomes and experiences while reducing costs. Additionally, her volunteer work with the Opioid Task Force reflects her commitment to public health advocacy and community well-being.GUEST: Scott Weiner, MD, MPH, FAAEM, FACEP, FASAMEmergency and Addiction Medicine Physician, Brigham and Women's HospitalAssociate Professor, Harvard Medical SchoolCo-chair, Clinical Advisory subcommittee, CHIME Opioid Task ForceBio: Dr. Weiner is the McGraw Distinguished Chair in the Department of Emergency Medicine at Brigham and Women's Hospital and an Associate Professor of Emergency Medicine at Harvard Medical School. He is board-certified in emergency medicine and addiction medicine. He is an active researcher, working on multiple projects that focus on prevention and treatment of opioid use disorder.GUEST: Arjun Venkatesh, MD, MBA, MHSChair, Department of Emergency Medicine, Yale University School of MedicineChief, Emergency Medicine, Yale New Haven HospitalBio: Dr. Venkatesh is Chair and Chief of Emergency Medicine at the Yale University School of Medicine and Yale New Haven Hospital. He has received over $ 12 million in funding by the NIH, CMS, AHRQ, and CDC to develop measures and interventions that improve acute care outcomes and value. He has supported CMS's development of the Overall Hospital Quality Star Ratings, has led the development of quality measures for the Clinical Emergency Data Registry, and is PI of the Emergency Quality Network (E-QUAL). His work has produced over 200 publications and been implemented in numerous national quality and value programs. He is a graduate of Northwestern University School of Medicine, a proud graduate of the HAEMR Class of 2012 often referred to as the Greatest Class Ever, and completed the RWJF Clinical Scholars Program at Yale.Additional Resources:ACEP E-QUAL opioid initiativeCedr

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dean Erhardt, President & CEO of D2 Solutions. They discuss how specialty pharmacies can leverage technology and data analytics to navigate complex accreditation demands and automate high volume low value activity workflows so the expert clinicians can do what they do best - care for patients.

In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The "Pharmacy 50" Awards, recognizing the 50 Most Influential Leaders in Pharmacy, have officially been announced for 2024! This prestigious honor celebrates the most inspiring, innovative, and impactful figures in pharmacy who are driving advancements in patient care, business development, and industry reform. Now in its fourth year, the Pharmacy 50 saw a record-breaking 30% increase in peer recognition, demonstrating the growing influence of pharmacists across multiple sectors, including Community Pharmacy, Long-Term Care, Specialty Pharmacy, Health System, Digital Health, and more. Voting took place between November 15 and December 20, 2024, and this year's winners include some of the most distinguished names in the industry, with returning honorees and new leaders making their mark on pharmacy's evolving landscape.   Pharmacy 50 Class of 2024 (Listed by most votes) Anthony V. Minniti, BScPharm, RPh, FACA Jay Phipps, PharmD, MBA, FACA, FACVP Dr. Nhu Truong, PharmD Jeff Harrell, PharmD Naveena Gorrepati, PharmD Jeremy Counts, PharmD Darshan Kulkarni, PharmD, Esq. Shahida Choudhry, PharmD** (4-time winner) April Nguyen, PharmD, RAC, MPH Robin Barrett, PharmD Cody R. Morcom, PharmD, BCPS, LSSGBC Ethan Melillo, PharmD, CDOE Randy McDonough, PharmD, MS, BCGP, BCPS, FAPhA Chelsea Hustad, PharmD, CSP Greg Reybold, Esq. Renee Malarbi Rayburg, BPharm Walter Oronsaye, PharmD, MS Chidimma Gold Eneyo, PharmD Jessica Beal-Stahl, PharmD Tamar K. Lawful, PharmD, APh, CNGS DeLon Canterbury, PharmD, BCGP Frank Harvey, MBA Mike Johnston, CPhT-Adv Brent Edison, PharmD Aleata Postell Courtney B. Smith, PharmD, CSP, BCMTMS Jennifer Morrison, PharmD Katrina Azer, BPharm Josh Pirestani Bil Schmidtknecht Ultan McGlone, PharmD Katarina (Kati) Forbes, PharmD Christopher Bowens, PharmD Mahmoud Zegar, PharmD Alexandra (Ally) LaStella, PharmD Kunal Vyas Jenny Bingham, PharmD Shaun Jensen Fiona Sartoretto Verna Brandi Chane, PharmD Jonathan Ogurchak, PharmD, CSP, CPHIMS Jena Quinn, PharmD Jordan Smith, PharmD, AAHIVP, CPGx Chris Antypas, PharmD Lorneka Joseph, PharmD Derek Borkowski, PharmD Sue Ojageer, PharmD, CPGx Benjamin Jolley, PharmD Anisha Patel, BPharm Jeff Malone Pharmacy 50 Awards Ceremony - January 29, 2025 The official awards ceremony will be hosted at the Pharmacy Podcast Network headquarters in Brownsville, PA. The event will feature: A networking session at 2 PM ET The Pharmacy 50 LIVE Stream at 3 PM ET, where winners will be highlighted and interviewed Industry leaders, past winners, and special guests will be in attendance to celebrate the remarkable contributions of these pharmacy professionals. The Pharmacy 50 Awards were created to recognize individuals who are pushing the boundaries of pharmacy care. From technology and advocacy to clinical services and business innovation, this year's winners represent the best of the best across the pharmacy profession. "Each year, we see more pharmacists taking charge of their profession-leading change, innovating care models, and fighting for patient access. The Pharmacy 50 recognizes these change-makers and amplifies their voices," said Todd Eury, Founder of Pharmacy Podcast Network. This year's Pharmacy 50 Awards were proudly sponsored by RxInsider and Independent Pharmacy Cooperative (IPC), whose ongoing support of the pharmacy industry continues to fuel growth and advocacy. "RXinsider is thrilled to support the Pharmacy Podcast Network's Pharmacy50 Awards, celebrating the outstanding leaders and innovators shaping pharmacy. As a company committed to advancing pharmacy through education and innovation, RXinsider is honored to join this prestigious initiative that recognizes excellence and inspires progress." stated Gregory Cianfarani RPh, CEO of RxInsider. "We're excited to celebrate the achievements of our peers and contribute to highlighting the individuals and organizations making a meaningful impact in the pharmacy community." For more details about the Pharmacy 50 Awards, visit Pharmacy50.us About Pharmacy Podcast Network (PPN) Pharmacy Podcast Network is the leading media platform dedicated to pharmacy professionals, offering thought leadership, industry insights, and expert-driven content through podcasts, webinars, and live events. Since its founding in 2009, PPN has been the voice of pharmacy, covering community pharmacy, specialty pharmacy, digital health, advocacy, business development, and more.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles' Health & Life Sciences Practice Group and Candace Lerman, JD, at Rare Candace. They discuss the current impacts of AI on the healthcare space and how those within specialty pharmacy may implement AI in ways that prevent detrimental outcomes, stay compliant with evolving regulations, avoid legal pitfalls, and ultimately benefit patients.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Ketan Mehta, the visionary CEO of PrimeRx. They explore how the advancement of technology has changed the landscape of specialty pharmacy and ways digital integration can help specialty pharmacies achieve a patient-centric holistic ecosystem.

Jonathan Ogurchak, PharmD, CEO of Zeal Specialty Pharmacy and STACK, shares his innovative journey of transforming specialty pharmacy through smarter technology. Learn how he's empowering pharmacists, improving patient outcomes, and disrupting the industry with his dual focus on pharmacy operations and groundbreaking tech solutions. A must-listen for pharmacy innovators!

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Bridgette Kanz Schroader, PharmD, MPA, BCOP, Associate Director within the Medical Affairs Strategy & Publications team at Market Access & Healthcare Consulting, part of Cencora, and Laurie Fayzio, Head, Manufacturer Strategy, at FormularyDecisions. They explore the changing landscape of digital communication between biopharma companies and healthcare decision makers (HCDMs) and delve into 3 key topics that are crucial for effective engagement in the digital era with key decision makers: research on how HCDMs are utilizing digital resources and valuable insights into their preferences, how biopharma companies are adapting to meet the evolving needs of HCDMs in a post-pandemic peak era, and innovative strategies to optimize digital communications and the implications for stakeholder relationships.

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Shaun Jensen, JB Consulting  Rafael Saenz, Chief of Staff at APhA Reed Kalna, PharmD Chairman of the Specialty Pharmacy Certification Board Russell Robbins MD, MBA & Diane Faraone, PharmD | PurpleLab Charles Collins, President at Healthcare Stakeholder Solutions Courtney Smith, PharmD Elsen Jacob, PharmD, MS Cencora Steven Garceau, Senior Director of Payer Strategy Andrew Babb, Biotech Remedies Shelia Arquette, Closing NASP

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Amy Niles, the Chief Mission Officer of the PAN Foundation, about the impact of advocacy and education on enhancing access to care in the face of rising health care costs, the 2025 Medicare reforms and what NASP members need to know, as well as the many initiatives and tools the PAN Foundation employs to help patients who might otherwise walk away from the pharmacy counter.   

Perigon Pharmacy 360 Chris Antypas PharmD Harry Travis NASP 2024 Jeff Wandzura KEEP Labs Shawn Francis PharmD | Children's National Hospital Richard Brook President | Better Health Worldwide Eric Huckins LumiceraHealth

This Week in Pharmacy – November 9, 2024 Episode Title: Addressing Patient Needs and Advocacy with Jennifer Noonan, VP of Clinical Strategy and Patient Engagement Show Notes: In this insightful episode of This Week in Pharmacy, we welcome Jennifer Noonan, Vice President of Clinical Strategy and Patient Engagement at Accessia Health, to discuss the current and future landscape of patient care. Join us as we explore the unique needs of patients, particularly within specialty pharmacy, and uncover resources that can provide crucial support. Conversation Highlights: Current State of Patient Care Jennifer shares her perspective on the pressing needs of patients today and whether their financial, educational, and advocacy needs are being adequately met. We delve into the varying needs of patients with different disease states and explore the specific support required for those navigating complex healthcare journeys. Discussion points include: Financial Assistance – Understanding the essential financial support patients seek and how various programs step in to alleviate the burden. Patient Advocacy and Education – Highlighting the importance of patient education programs and recent efforts like the CMS webinar series to empower patients. Health Equity and SDOH – Addressing the gaps in social determinants of health and equity in care, and how they impact patient outcomes. Resources Available to Patients Jennifer discusses often-overlooked resources like Patient Assistance Programs (PAPs), especially Accessia Health's support beyond copay assistance. Listeners gain insight into: Financial Support Programs – Beyond the basics, Accessia Health provides comprehensive assistance tailored to specific patient needs. Educational Programs – How initiatives such as CMS webinars bridge knowledge gaps and empower patients to make informed choices. Filling Gaps in Health Equity – Steps being taken to close disparities and ensure all patients have access to equitable care. Future of Specialty Pharmacy and Patient Engagement Jennifer shares her outlook on the changes expected in the specialty pharmacy space over the next few years. Topics include: Rising Healthcare Costs and Legislation – How the Inflation Reduction Act (IRA) and upcoming CMS changes could reshape the landscape for patients. Cell and Gene Therapy Advances – The impact of groundbreaking treatments and the importance of ensuring patients have access to these innovations. Getting in Touch with Accessia Health Jennifer concludes with ways patients, caregivers, and healthcare providers can connect with Accessia Health to learn more about the resources and support available. Connect with Us: For more information about this episode and to reach out to Accessia Health, visit AccessiaHealth.org. Don't forget to subscribe to This Week in Pharmacy for the latest insights in healthcare and pharmacy. Join us as we uncover how healthcare professionals, patients, and advocates can come together to address today's challenges and build a more inclusive future for all.

Accessia Health 12 min Jennifer Noonan RN Jonathan Orguchack Stack NASP Juliana DeFrancis BlueSky Specialty Pharmacy Mei Tang, Pharm.D., MBA | Two Trees Consulting Michael Meader Altor Solutions Cold Packs Mike Baldzicki (sp) Nick Ruiz keycentrix Allison Arant Clearway Health

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, visits with Mary Oates, MD, US Medical Lead, Bone Franchise with Amgen, to discuss post menopausal osteoporosis and what clinical pharmacists can do to support patients.  

AcariaHealth (Sponsored) Aleata Postell, Senior Director | Walmart Specialty Orlando Vidal Jeffrey S. Baird | Brown & Fortunato Sarah Allen NavenHealth Ceceila Byers Surescripts Jon Hamrick, MBA, Cheryl Allen, BS Pharm, MBA, | Curatio Scientia

About Vic Simianu and Sphinx Strategies: Coming from a background in Biotechnology and Finance with an MBA from Kelley's School of Business, Vic is an entrepreneur focused on helping specialty pharmacies make key strategic investment decisions to differentiate themselves in the marketplace. Vic has achieved outstanding results throughout his career leading business decisions for a broad range of healthcare and pharmaceutical industry players, and is passionate about developing innovations within the healthcare space. Our mission is to become the nation's most trusted independent specialty pharmacy consulting group, creating value for our clients and staff while catalyzing clinical, operational, and financial performance for our clients. Sphinx Strategies is a consulting group focusing on developing and maintaining highly-integrated and collaborative Specialty Pharmacy operations. While Payors and PBM's continue to force adoption of enhanced competitive requirements, specialty pharmacies face the compounded effect of time constraints, regulatory hurdles, and constant reimbursement challenges. Sphinx Strategies targets the effectiveness and speediness of their approach by combining efforts in accreditations, operational excellence, and data analytics in each phase of their projects for clients to achieve and surpass double and triple-digit ROI's per engagement. The Sphinx portfolio of clients range from independent pharmacies to large IDN's, ACO's, and publicly traded pharmacies and insurers. Accreditations often lay the foundation for specialty pharmacies to compete in the marketplace and develop key partnerships paramount to success in the industry. Being one of the first ACHC-Certified Specialty Pharmacy Consultants as well as achieving one of the first URAC Specialty Pharmacy accreditations, Vic has ridden the exponential growth within the SP industry as accreditations have become primary differentiators for pharmacies. He intimately understands the nature and history of the accrediting bodies, the rapid evolution of the accreditation standards themselves, and the ever-expanding value behind engaging and maintaining accredited processes.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Stuart Kamin, SVP of Analytics and Innovation at Claritas Rx about the evolution of personalized medicine, the impact that it's had on market and patient access teams, and the use of data analytics and AI to support the patient experience.  

On #TWIRx "This Week in Pharmacy" --we start out with the WORLD WIDE Celebration of Pharmacists, World Pharmacist Day 2024, thank you to all the 4-Million Pharmacists on planet Earth. On September 25, 2024, the global community came together to celebrate World Pharmacists Day, shining a spotlight on the invaluable role pharmacists play in safeguarding public health. (Shout out to Katrina Azer & Anisha Patel)  HARMACY Film -- huge announcement from Dr. Anaïs Webster- Mennuti, Dr. Kristin Speer, and Marie Wilda! Go to HarmacyFilm.com  Thank you Josh Kent from Cannabis Pharmacy, forwarding education, programs to support independent pharmacy businesses, and delivering highest quality products, check them out CannabisPharmacy.com -- and the Education leaders from the Answer Page with Dr. Stephen Corn, M.D. and Dr. Meredith Fisher-Corn, M.D, they joined the Pharmacy Podcast Network for reliable education for healthcare providers.  Thank you Sykes & Company for your services for Pharmacy Owners and accounting management to 'Master the Margins' of your businesses. The Road-Trip Guy is back with another 'Pharmacy CrossRoads' host Bruce Kneeland. This episode is about growing your compounding pharmacy business. We're proud of the Pediatirc Pharmacist leaders, 'Perfecting Peds' and their latest podcast episode on CFTR (Cystic fibrosis), take a listen!  Cardinal Health is focused on 'Why Independent Pharmacy' with Barry Christensen on 'Counter Talk' podcast --this is a great podcast about why it's time to build your community pharmacy, Cardinal Health is ready help build your pharmacy in 2025.  What's QHIN and how is Surescripts leading the way in 'qualified health information networks' will impact healthcare. We had a wonderful discussion lead by Dr. Simi Burn, PharmD, with special guests Ashton S. Maaraba, J.D. with IPC and Ritesh Patel with FINN Partners for being part of this discussion about #DigitalHealth inside Community Pharmacy today.  The 50 Most Influential People in Pharmacy Awards are getting ready to launch! Who do you think is an influential leader in Pharmacy Care? We're so proud to be launching the 4th #Pharmacy50 Awards in October 2024. Shout Out to the # 1 for 2023, Dr. Nadia Ahmad, PharmD --with Walgreens. Thank you Nadia for a special recognition of my work in pharmacy, thank you.  First featured guest today on TWIRx is a specialty pharmacy 'Slayer of Healthcare Barriers' Jennifer Noonan, MSN, RN, with Accessia Health, helping patients find funding for their medications when all hope seems lost, this company fights for the patient's pharmacy care.  Perigon Pharmacy 360, President Dr. Chris Antypas, PharmD., will be featured at the NASP Annual Event on the PPN's PRess coverage of the conference and he's here with us on TWIRx. Chris shares about how his specialty pharmacy is combining technology, pharmacy care plans, specialty & rare disease specialty pharmacists to innovate pharmacy care.  Shaun Jensen with JB Consulting will be at NASP ready to talk about helping Specialty Pharmacies build custom systems, software programs, and APIs to make your workflow, your mobile apps, and how to best leverage A.I. to help dial into your specialty pharmacy operations on another level. Shaun and his team build powerful programs specific to your operations needs. We can't wait to talk with Shaun in Nashville.  Thank you Shelia Arquette, CEO of the NASP for your unwavering support of Specialty Pharmacy excellence. Your impact on specialty care has been incredible. See everyone in Nashville. 

In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. In this segment, you'll hear from Prime's Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You'll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey. As a bonus, Steve also talks about how Prime's new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Gary Conte, Vice President of Business Development with HealthPlan Data Solutions (HDS), about innovations in prescription analytics that allow for daily script-level insights into the performance and trends of specialty pharmacy business.

This episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Kathryn Eshelman, MD, MPH, Vice President of Clinical Informatics at Inovalon, about the evolving role of pharmacists and how leveraging technology can enhance patient outcomes while reducing administrative burdens.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-leaders of the Health Care Controversies Team at Barclay Damon, about the recent Federal Trade Commission (FTC) interim report on Pharmacy Benefit Managers (PBMs), challenges specialty pharmacies experience when impacted by anti-competitive practices, and a future for specialty pharmacy that broadens the profession and continues to facilitate excellent patient care.

Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources.  Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Sheila Arquette, President & CEO of NASP, speaks with Tim McLeroy, Executive Director of Marketing & Patient Services at Noble International, and Terry Spalding, Senior User experience/Human factors Researcher at Noble International and a Registered Nurse

In this episode, listen in as our expert panel discusses the challenges and solutions for ensuring access to specialty medications, including how social determinants of health play a role and strategies to overcome barriers caused by these factors.Our panel for this conversation includes: Laura Sosinski, PharmD, MBA, BCPS; Pharmacy Manager, Walgreens Specialty Pharmacy; PGY1 Community Pharmacy Residency DirectorPatricia Romero, PharmD, CSP; Pharmacist, Walmart Specialty Pharmacy Rachel Popp, CPhT; Patient Panelist; Contact Center Specialist, Walmart Specialty PharmacyJake Galdo, PharmD, MBA, BCPS, BCGP; CEO, Seguridad, Inc; Managing Network Facilitator, CPESN Health EquityMeredy Ayers, CPhT-Adv, CHW; Development Specialist, Bremo PharmacyNone of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast episode. Log in to your Pharmacist's Letter,Prescriber Insights, or Pharmacy Technician's Letter account and look for the title of this podcast in the list of available CE courses. Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Guide for Helping Patients Afford Their MedicationsFAQ: Facts About BiosimilarsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Welcome to "The Dish on Health IT," a podcast brought to you by Point-of-Care Partners, a leading health IT consultancy. Each episode features a rotating panel of senior consultants and guests who discuss trends and innovations in health IT, providing insights and recommendations to help organizations leverage advances to solve their business problems.In this episode, POCP hosts Tony Schueth, CEO of Point-of-Care Partners, and Pooja Babbrah, PBM and Pharmacy Lead, are joined by Shivani Patel, Executive Vice President of Patient Access Operations and Technology Solutions at Asembia. Together, they delve into key topics including specialty prescribing, pharmacy interoperability, TEFCA, and consent management, highlighting how technology, policy, and process improvements can drive positive changes in healthcare.The conversation kicks off with an introduction to specialty prescribing. Shivani explains that specialty prescribing involves treatments that are typically more complex than standard prescriptions due to factors like high cost, special storage requirements, and adherence challenges. She points out the logistical gaps and barriers in the specialty space, such as prior authorizations and communication challenges between stakeholders. Pooja adds that the lack of a standardized definition for specialty medications further complicates the process, leading to delays and confusion.Moving on to pharmacy interoperability, Pooja describes it as the ability to share clinical data between pharmacists, providers, and other stakeholders. She emphasizes the importance of providing pharmacists with the right information they need, instead of overwhelming them with excessive data. For instance, pharmacists should not have to sift through 500 pages of patient records to find relevant information. Instead, they need targeted, pertinent data to improve patient care and streamline processes.The discussion then shifts to TEFCA (Trusted Exchange Framework and Common Agreement), which aims to fill information gaps in the healthcare system by setting standards for data exchange. Shivani and Pooja discuss how TEFCA can enhance transparency and interoperability, helping pharmacists and other stakeholders' access and share necessary patient information more efficiently. Shivani notes the potential of TEFCA to establish a universal patient identifier, which could significantly improve data sharing and patient care coordination.Consent management is another crucial topic covered in this episode. Effective consent management is essential for pharmacy interoperability and ensuring patients' privacy and data security. Shivani and Pooja explore how consent management can be improved to make the sharing of patient information more seamless and secure. They emphasize the need for standardized consent processes that allow patients to control their data while ensuring that relevant information is accessible to healthcare providers.Throughout the episode, the panel highlights the role of technology in improving the prescription journey. Shivani discusses how Asembia uses technology to support the industry by connecting stakeholders and providing tools to manage patient care better. This includes everything from prior authorizations to benefit checks and copay cards. Pooja underscores the importance of industry collaboration and transparency to create standardized solutions that benefit all stakeholders.Towards the end of the episode, Shivani shares insights about the Asembia Summit, an annual event that gathers industry stakeholders to discuss trends and innovations in specialty pharmacy. She invites listeners to attend AXS25, the next Asembia Summit, which will take place from April 27th to May 1st, 2025, at the Wynn Las Vegas. The event offers a premier forum for learning, networking, and exploring the latest advancements in the industry.Tune in to this episode to gain a deeper understanding of the complexities of specialty prescribing, the importance of pharmacy interoperability, and how collaborative efforts in technology, policy, and process can enhance healthcare delivery. Don't miss the insights shared by industry stakeholders on why they attend the Asembia Summit each year. For more information and to suggest future topics, email us at podcast@pocp.com or tweet us at @POCPHIT.

In this episode, host Dr. Christina Madison interviews Aleata Postell, group director of pharmacy business development, Walmart, to discuss the significance of specialty pharmacy services—particularly related to HIV care—in public health. Postell highlights how Walmart has initiatives that support HIV care and testing. Key Takeaways: Community Pharmacy's Role in Public Health: The episode highlights the critical role community pharmacies—such as Walmart—play in public health, particularly in providing accessible specialty care and HIV services. By meeting patients where they are and integrating services into a familiar setting, community pharmacies can effectively support patients' comprehensive health needs, including specialized care for HIV. Importance of Reducing Stigma and Enhancing Education: Aleata Postell shares her personal motivation and experiences, emphasizing the need to reduce stigma around HIV and other specialty conditions. Education and awareness, both within the community and among health care providers, are crucial for improving care and ensuring patients feel comfortable seeking treatment and support.  Innovative Public Health Initiatives: Walmart's collaboration with the Elton John AIDS Foundation and Gilead have helped expand the organization's HIV testing and care services. By increasing the number of testing sites and providing community health workers and specialized training for pharmacists, Walmart is taking significant steps to enhance public health infrastructure and support for individuals living with HIV. You can check out the following discussed resources: Walmart Specialty Pharmacy—HIV: https://www.walmart.com/cp/specialty-pharmacy-of-the-community/6730561?povid=OMNISRV_D_Cp_HW_HwSpecialtyPharm_4101489_HW_6730561_TileCardsService_HivSpecialtyPharmacy_LearnMore_1332399668 International Association of Providers of AIDS Care: https://www.iapac.org/ Elton John AIDS Foundation: https://www.eltonjohnaidsfoundation.org/what-we-do/what-we-fund/breakthrough/ Connect with Aleata Postell and follow Walmart Specialty Pharmacy on LinkedIn!

This Becker's Healthcare Podcast episode dives into the world of specialty pharmacy. Host Brian Zimmerman chats with Nicole Faucher, President of Clearway Health, about why hospital executives should pay attention to this growing field. They explore common misconceptions surrounding specialty pharmacy and offer insights on how healthcare leaders can assess their own opportunities for expansion in this area.This episode is sponsored by Clearway Health.

In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician. Any legal information included in this podcast is for our listeners' educational purposes only.  It is not intended as legal advice.  If you have specific legal questions, you should contact the legal department of your organization or outside counsel.

Champ Burgess, PharmD, MBA, is Vice President, Health System Strategy for Shields Health Solutions. You'll hear about the Shields Care Model and their impact on health system specialty pharmacy. We also discuss top issues impacting specialty pharmacy. Dr. Burgess and I previously worked together so we talk through this career path including our time as Assistant Directors together. Enjoy all things specialty pharmacy in this episode!

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jeffrey S. Baird, JD, Chairman of the Health Care Group at Brown & Fortunato. Health care providers, including pharmacies, must play by a set of rules that non-health  care providers do not have to follow. A principal reason for this is that a large portion of payments to providers comes from government programs (Medicare, Medicaid, TRICARE, etc.). Because tax dollars are involved, pharmacies must comply with an array of  federal and state fraud laws. These laws come into play when pharmacies work with referral sources such as physicians, hospitals, home health agencies and labs. Sheila and Jeffery discuss important federal laws such as the anti-kickback statute, physician  self-referral statute (“Stark”), beneficiary inducement statute, and False Claims Act. They also discuss examples of similar state laws, types of arrangements pharmacies can legally enter into with referral sources…and the types of arrangements that should  be avoided.

Matt Grissinger, RPh, FISMP, FASCP is the Director of Education at the Institute for Safe Medication Practices (also known as ISMP).  During our conversation, we talk about ISMP's Targeted Medication Safety Best Practices for Community Pharmacy first.  Then, we talk about how to report an error, CPE available from past ISMP webinars, adding education on operations to the pharmacy school curriculum, and more.  This is a great episode for any pharmacist, pharmacy student, pharmacy technician, or pharmacy owner.  Medication Safety is important.     Thank you for listening to episode 280 of The Pharmacist's Voice ® Podcast!   To read the FULL show notes, visit https://www.thepharmacistsvoice.com/podcast.  Select episode 280.   Subscribe to or follow The Pharmacist's Voice ® Podcast to get each new episode delivered to your podcast player and YouTube every time a new one comes out!     Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Bio (May 2024) Matthew Grissinger, RPh, FISMP, FASCP is the Director of Education at the Institute for Safe Medication Practices (ISMP). He first joined ISMP in 2000 as an ISMP Safe Medication Management Fellow. Prior to joining ISMP, he served as a home care and long-term care pharmacy surveyor for the Joint Commission. He was project leader for the Hospital and Healthsystem Association of Pennsylvania (HAP) Hospital Improvement Innovation Network's (HIIN) Adverse Drug Event (ADE) Project, a collaborative project engaging healthcare organizations to reduce and prevent patient harm from the use of anticoagulants, insulins, and opioids. He has published numerous articles in the pharmacy literature, including regular columns in P&T and is a journal reviewer for a number of publications including the Joint Commission Journal on Quality and Patient Safety, Pharmacoepidemiology, Journal of Managed Care and Specialty Pharmacy, BMJ Quality and Drug Safety, and Annals of Internal Medicine. He is a chapter contributor to a textbook published by McGraw-Hill entitled Pharmacy Management: Essentials for All Practice Settings, Essentials of Nurse Informatics, Remington: The Science and Practice of Pharmacy, and Medication Errors. He is recently completed the Just Culture certification course. Mr. Grissinger serves as the Chair for the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), and Co-Chair of the National Quality Form (NQF) Common Formats Expert Panel. He is also on the Faculty Advisory Board for the Pharmacy Learning Network (PLN) and the Publications Advisory Board for Davis's Drug Guide for Nurses. He also served on the WHO Focus Group on Measurement Tools for Medication Safety, United States Pharmacopeia's (USP) Safe Medication Use Expert Committee from 2005-2010, the FDA Proprietary Name Review Concept Paper workshop panel in 2008, FDA Naming, Labeling, and Packaging Practices to Minimize Medication Errors workshop panel in 2010 and the Joint Commission Home Care Compounding Pharmacy Technical Advisory Panel in 2013. He is also an adjunct assistant professor for Temple University School of Pharmacy. Mr. Grissinger received a BS in Pharmacy from the Philadelphia College of Pharmacy and Science and is a fellow of the Institute for Safe Medication Practices as well as the American Society of Consultant Pharmacists.   Subscribe to or follow The Pharmacist's Voice ® Podcast to get each new episode delivered to your podcast player and YouTube every time a new one comes out!     Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Links from this episode Matt Grissinger on LinkedIn https://www.linkedin.com/in/matthew-grissinger-63231ab/  ISMPs new website

I interviewed Tracey James, chief operating officer, Walgreens Specialty Enterprise about how Walgreens is trying to improve affordability and accessibility of specialty drugs. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Tracey James erin.loverher@walgreens.com   Review, Subscribe and Share If you like what you hear please leave a review by clicking here Make sure you're subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts Click here to subscribe with Spotify Click here to subscribe with Podbean Click here to subscribe with RSS

Join Champ Burgess, VP of Business Development and Health System Strategy at Shields Health Solutions, as he discusses the power of an integrated specialty pharmacy care model and how Shields is helping to optimize patient care. Learn more about how Shields helps health systems prioritize specialty pharmacy patient care by reducing the burden of administrative tasks on clinicians while maintaining leading patient outcomes. #ElevatingSpecialtyPharmacyExplore our whitepaper, "The Impact of Specialty Pharmacy on Clinician Allocation," for insights into workforce management challenges in healthcare and solutions provided by Shields. Access it here to optimize clinician utilization amidst administrative burdens.This episode is sponsored by Shields Health Solutions.

In the first of a series of episodes exploring opportunities for innovation in the pharmacy space, Mark Cuban offered perspective from an outsider intent on disrupting the status quo. In this, the second episode, Dr. Troyen Brennan gives an insider point-of-view from someone who has studied and worked in the space for decades.Dr. Brennan was Chief Medical Officer at CVS Health for nearly 14 years, and before that, Chief Medical Officer at Aetna for two years. He was also a practicing physician at Brigham and Women's Hospital for 15 years where he was president of Brigham and Women's Physician Organization. During that time, he was also Professor of Medicine at Harvard Medical School and Professor of Law and Public Health at the Harvard T.H. Chan School of Public Health. He is the former Chair of the American Board of Internal Medicine and has published six books and more than 600 articles offering his insight into the American healthcare system, and his ideas on how to improve it.With extensive knowledge of how the industry has evolved, and an understanding for why many of the complexities in the industry exist, Dr. Brennan offers a unique viewpoint about where and how disruption in the pharmacy space can succeed. In his eyes, the idea of good and bad actors in the pharmacy space is a false narrative. With an historical perspective, he explains how industry processes were all sensible when they were first implemented, and how that viewpoint is critical to understanding and addressing some that may have become seemingly senseless over time. A few of the topics he discussed with Keith Figlioli in this Healthcare is Hard episode include:Six ways PBMs have lowered cost. Dr. Brennan provides a history of pharmacy benefits managers (PBMs), why they were created in the late 1950s and how they have helped the pharmacy industry. He discussed his thoughts on the six things PBMs have done – and are still doing – to help control costs. These include expanding the use of mail order pharmacies, sourcing generic drugs, introducing tiered pricing, implementing prior authorization and utilization management, assembling pharmacy networks, and negotiating rebates.Flexibility of PBMs. When discussing the future role PBMs may or may not play in the industry, Dr. Brennan says he's confident in the ability for big PBMs to adapt. He believes they've proven to be more flexible than other parts of the healthcare system and will continue to have significant influence as regulations evolve and disruptors enter the market. He says that Mark Cuban is having a good influence on the industry overall with Cost Plus Drug Company, but would bet on the ability of PBMs to adapt.The path to greater affordability. With new, life-changing therapeutics being introduced regularly and specialty pharmacy expected to become a significant portion of healthcare spending, Dr. Brennan discusses some of the potential options for ensuring these treatments are affordable. He believes entrepreneurs disrupting the space can help contribute, but regardless of the role they play, says government will ultimately have to step in with price controls. He points to the role government plays controlling the costs of hospital services and says it will eventually have to play a similar role in the pharmacy space.To hear Dr. Brennan and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

A big part of total national drug spend is the continuing growth of the specialty drug market. Health systems depend on specialty pharmacy to make up margin losses from other areas. Dr. Vinay Eapen, Senior Manager of Specialty Pharmacy at University of Texas Medical Branch, joins Gretchen Brummel, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program to share a bold approach to starting specialty pharmacy services at an academic medical center.   Guest speakers:  Vinay Eapen, PharmD Ambulatory Specialty Pharmacy Supervisor UTMB – League City   Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence     Show Notes:  [00:46-01:09] Dr. Eapen background information  [01:10-01:52] History of the specialty drug market [01:53-02:43] Categorizing specialty drugs [02:44-03:26] When UTMB decided to start a specialty program [03:27-04:18] Building the program [04:19-05:25] Benefits of the program [05:26-06:11] Unexpected issues [06:12-06:54] Where specialty pharmacy is going [06:55-07:37] Advice for other starting specialty pharmacy programs [07:38-08:21] Reasons to start a specialty pharmacy   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, chats about A.I. in Specialty Pharmacy with Carl Mazzanti, Co-Founder and President of eMazzanti Technologies, Microsoft's four-time Partner of the Year and one of the premier IT consulting services for businesses throughout the New York metropolitan area and internationally.  Sheila Arquette, President & CEO of NASP, Carl Mazzanti, Co-Founder and President of eMazzanti Technologies

In this Pharmacy Leadership Episode, Denise Scarpelli, the Chair for the Section of Specialty Pharmacy Practitioners, sits down with SSPP's Distinguished Service Awardee Matt Rim to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Bethany Kalich, PharmD, CLS, a Cardiovascular Medical Director and Asset Lead for the US Medical Team. Tune in for a conversation on the critical role of pharmacists and healthcare agencies in addressing gender inequalities in cardiovascular health. Sheila Arquette, President & CEO of NASP, speaks with Bethany Kalich, PharmD, CLS

In this 9-minute conversation, the CTO at Free Market Health, Mark Conklin, dives into the evolving specialty pharmacy landscape and its impact on payers. The discussion focuses on the complexities of the ecosystem, why the status quo is no longer working, and what payers can expect in the new year. Tune in to gain valuable insights on the changing world of specialty pharmacy, how technology is driving innovation, and more.This episode is sponsored by Free Market Health

Welcome Mike Agostino & Joe Platten with NASH – Network of Advanced Specialty Healthcare Why Travel-for-Treatment An increasing number of Americans are opting to travel abroad for their medical needs, encompassing services such as orthopedic procedures, bariatric surgery, plastic surgery and fertility treatments. Additionally, the utilization of specialty medications is increasing. These medications treat complex health conditions and frequently come with unaffordable costs in the U.S., prompting a necessity to seek options across U.S. borders for safe, affordable specialty medications.

RxSafe was pleased to sponsor How Specialty Pharmacies are Revolutionizing Patient Compliance.  Hosted by Todd Eury, publisher of the Pharmacy Podcast Network, the webinar included guests: •    Brad Livingstone, PharmD, Owner, Sound Specialty Pharmacy •    Matt Gilbert, VP of Strategic Accounts, RxSafe “Pharmacy runs through this guy's veins,” says Eury, speaking of Brad Livingstone. “He's been expanding his pharmacy businesses from compounding to community pharmacy, specialty, mixed long-term care, and the services that have been critical to the communities where he operates.”

Lumicera is unique in that it was one of the first to provide transparency to the market. It became the first national, Cost+ Specialty Pharmacy providing clients with true acquisition plus a flat patient management fee pricing model utilizing First-In-First-Out (FIFO) inventory pricing model. Lumicera serves Navitus members, a PBM that employs a full pass-through model, where they pass 100% of all network discounts and pharmaceutical manufacturer rebates they receive directly back to the client, and just celebrated their millionth shipment of specialty medications.

Episode 3 of the NASP Post Show! In this episode we talk with Nicholas Ruiz - keycentrix Richard Brook - Better Health Worldwide / NPRT Russel Robbins - PurpleLab Saumya Rawat - Pharmesol David Bronstein - Specialty Pharmacy Continuum Tim McLeroy - Noble International

Jennifer Donovan, Pharm D, is the vice president of clinical services at Shields Health Solutions. In this role, Jen leads the Clinical Services, Training and Outcomes teams. She's responsible for ensuring Shields provides best-in-class patient care that's evidence-based and adheres to external requirements, working cross functionally with various departments. Prior to Shields, Jen was the Associate Dean for the School of Pharmacy – Worcester/Manchester and Professor of Pharmacy Practice at Massachusetts College of Pharmacy and Health Sciences in Worcester, MA. Jen earned a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences and completed a pharmacy practice residency at UMass Memorial Medical Center. Jen lives in the New England area with her husband and two kids.